TuisCHGCY • OTCMKTS
add
Chugai Pharmaceutical ADR
Vorige sluiting
$22,45
Dagwisseling
$21,90 - $23,68
Jaarwisseling
$19,50 - $31,26
Markkapitalisasie
11,76 bn JPY
Gemiddelde volume
190,47 k
P/V-verhouding
-
Dividend-opbrengs
-
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (JPY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 333,18 mjd | 5,54% |
Bedryfskoste | 76,45 mjd | 7,60% |
Netto inkomste | 111,21 mjd | 1,57% |
Netto winsgrens | 33,38 | -3,78% |
Wins per aandeel | — | — |
EBITDA | 156,78 mjd | -2,50% |
Effektiewe belastingkoers | 28,74% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (JPY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 882,45 mjd | 4,39% |
Totale bates | 2,18 bn | 5,50% |
Totale aanspreeklikheid | 293,48 mjd | 9,36% |
Totale ekwiteit | 1,89 bn | — |
Uitstaande aandele | 1,65 mjd | — |
Prys om te bespreek | 0,02 | — |
Opbrengs op bates | 17,54% | — |
Opbrengs op kapitaal | 20,19% | — |
Kontantvloei
Netto kontantverandering
| (JPY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 111,21 mjd | 1,57% |
Kontant van bedrywe | 71,09 mjd | -42,50% |
Kontant van beleggings | 93,92 mjd | 349,97% |
Kontant van finansiering | -207,79 mjd | -198,95% |
Netto kontantverandering | -40,66 mjd | -498,71% |
Beskikbare kontantvloei | 42,78 mjd | -38,05% |
Meer oor
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
HUB
Gestig
10 Mrt. 1925
Webwerf
Werknemers
5 026
